Gfs Advisors, LLC Laboratory Corp Of America Holdings Transaction History

Gfs Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 21, 2022	SELL	$271.6 - $314.21 $257,205 - $297,556	-947 Closed	0 $0
Q3 2021 Nov 03, 2021	SELL	$274.82 - $308.34 $13,741 - $15,416	-50 Reduced 5.02%	947 $267,000
Q2 2021 Jul 26, 2021	BUY	$251.87 - $278.14 $251,114 - $277,305	997 New	997 $275,000
Q1 2020 May 05, 2020	SELL	$104.32 - $195.28 $138,745 - $259,722	-1,330 Closed	0 $0
Q3 2019 Oct 31, 2019	BUY	$159.77 - $178.1 $212,494 - $236,873	1,330 New	1,330 $223,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Gfs Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Gfs Advisors, LLC with notifications on news.